Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Norepinephrine Transporter Blockade, Autonomic Failure IND117394 12/28/12

NCT02784535 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT02784535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02784535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Norepinephrine Transporter Blockade, Autonomic Failure IND117394 12/28/12
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
August 29, 2016
Completion date
June 30, 2023
Enrollment
48 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic orthostatic hypotension